Elanco's 2026 revenue beats mid-single-digit guidance

Elanco raised its 2026 revenue guidance to mid-single-digit growth, implying at least 5% year-over-year increase. Strong pet medication demand and livestock health sales are expected to drive performance above the midpoint.

Implied probability (Yes)

78%